Kisspeptin-54 Side Effects: Safety Signals and Warnings
Kisspeptin-54 safety concerns are compound-specific. The main listed side effects are Facial flushing, Nausea, and Headache. The main warning signals are Investigational - not approved for clinical use, Tachyphylaxis observed with continuous or repeated dosing, and May cause ovarian hyperstimulation in susceptible patients.
Direct Answer
Kisspeptin-54 has Phase 2 human data on HPG axis activation, showing LH pulse stimulation and potential applications in infertility and hypothalamic amenorrhea. The mechanism - upstream of GnRH - is genuinely differentiated. Evidence is early but comes from well-conducted university-based human trials. A credible emerging candidate for HPG axis fertility research, though far behind GnRH analogs in development stage.
- Evidence grade
- Level C
- Research status
- Phase 2
- Category
- Sexual Health
- Best for
- HPG axis activation research, hypothalamic amenorrhea, male and female fertility investigation
Reported Side Effects
- Facial flushing
- Nausea
- Headache
- Injection site discomfort
- Hot flashes (related to gonadotropin surge)
Warnings
- Investigational - not approved for clinical use
- Tachyphylaxis observed with continuous or repeated dosing
- May cause ovarian hyperstimulation in susceptible patients
- Not for use in patients with KISS1R mutations (no response expected)
Known or Plausible Interactions
- GnRH agonists/antagonists (may interfere with kisspeptin's effect on GnRH release)
- Gonadal steroids (estrogen and progesterone modulate kisspeptin neuron activity)
- Neurokinin B modulators (KNDy neuron co-transmitter interactions)
Regulatory Context
Investigational. Not FDA-approved. Available for research purposes and in clinical trials. Not a controlled substance.
Evidence Snapshot
| Evidence grade | Level C |
|---|---|
| Research status | Phase 2 |
| Best supported outcomes | LH/FSH Stimulation (Level B), Oocyte Maturation Trigger (IVF) (Level C), and Reproductive Axis Activation (Level C) |
| Primary citation count | 3 |
| Last reviewed | 2026-04-04 |
Related Guides
How to Cite This Page
ExaminePeptides. "Kisspeptin-54 Side Effects: Safety Signals and Warnings." Last reviewed 2026-04-04. https://examinepeptides.com/answers/kisspeptin-54-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.